The evolution of mendelian randomization for investigating drug effects

Dipender Gill and Stephen Burgess discuss the accompanying study by James Yarmolinsky and colleagues investigating the associations between genetically-proxied inhibition of antihypertensive drug targets and risk of common cancer subtypes using Mendelian randomization.

Detalles Bibliográficos
Autores principales: Gill, Dipender, Burgess, Stephen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812877/
https://www.ncbi.nlm.nih.gov/pubmed/35113864
http://dx.doi.org/10.1371/journal.pmed.1003898
_version_ 1784644748114395136
author Gill, Dipender
Burgess, Stephen
author_facet Gill, Dipender
Burgess, Stephen
author_sort Gill, Dipender
collection PubMed
description Dipender Gill and Stephen Burgess discuss the accompanying study by James Yarmolinsky and colleagues investigating the associations between genetically-proxied inhibition of antihypertensive drug targets and risk of common cancer subtypes using Mendelian randomization.
format Online
Article
Text
id pubmed-8812877
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-88128772022-02-04 The evolution of mendelian randomization for investigating drug effects Gill, Dipender Burgess, Stephen PLoS Med Perspective Dipender Gill and Stephen Burgess discuss the accompanying study by James Yarmolinsky and colleagues investigating the associations between genetically-proxied inhibition of antihypertensive drug targets and risk of common cancer subtypes using Mendelian randomization. Public Library of Science 2022-02-03 /pmc/articles/PMC8812877/ /pubmed/35113864 http://dx.doi.org/10.1371/journal.pmed.1003898 Text en © 2022 Gill, Burgess https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Perspective
Gill, Dipender
Burgess, Stephen
The evolution of mendelian randomization for investigating drug effects
title The evolution of mendelian randomization for investigating drug effects
title_full The evolution of mendelian randomization for investigating drug effects
title_fullStr The evolution of mendelian randomization for investigating drug effects
title_full_unstemmed The evolution of mendelian randomization for investigating drug effects
title_short The evolution of mendelian randomization for investigating drug effects
title_sort evolution of mendelian randomization for investigating drug effects
topic Perspective
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812877/
https://www.ncbi.nlm.nih.gov/pubmed/35113864
http://dx.doi.org/10.1371/journal.pmed.1003898
work_keys_str_mv AT gilldipender theevolutionofmendelianrandomizationforinvestigatingdrugeffects
AT burgessstephen theevolutionofmendelianrandomizationforinvestigatingdrugeffects
AT gilldipender evolutionofmendelianrandomizationforinvestigatingdrugeffects
AT burgessstephen evolutionofmendelianrandomizationforinvestigatingdrugeffects

Ejemplares similares